東方集團(600811.SH)大股東東方潤瀾3.996億股質押延期
格隆匯4月20日丨東方集團(600811.SH)公佈,公司於2020年4月20日收到大股東東方潤瀾的通知,東方潤瀾與中信證券簽署了《股票質押式回購交易補充協議》,對其質押給中信證券的3.996億股股票辦理了股票質押式回購交易延期回購,佔公司總股本的比例為10.76%。變更後的質押到期日為2020年10月。
截止本公告披露日,公司實際控制人張宏偉、控股股東東方集團有限公司及其全資子公司西藏東方潤瀾投資有限公司作為一致行動人合計持有公司股份11.13億股,佔公司總股本的比例為29.96%,合計質押股份數量(含本次)為8.63億股,佔其合計持有公司股份數量的比例為77.56%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.